ArticleChembiochem : a European journal of chemical biology2026
Effects of Selenocysteine Substitution on the Cyclotide Kalata B2.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cyclotides are peptides with a head-to-tail cyclic backbone and six cysteine residues that are linked in a knotted arrangement. Their unique structure confers exceptional stability and various biological activities, resulting in numerous studies on their synthesis and development for a range of applications. One challenge in cyclotide synthesis is the formation of the correct disulfide bonds that fold the peptide into the native conformation. Replacement of a native disulfide bond with the faster-forming diselenide bond by substituting cysteine residues with selenocysteine is a strategy that can be implemented to overcome this issue. In this study, we synthesized selenocysteine analogs of the cyclotide kalata B2 and determined the effect of the substitution on folding, structure, and biological activity. The analogs folded faster than their native counterpart, implying that the diselenide bond assists in the formation of the correct structure. HPLC and nuclear magnetic resonance (NMR) analysis revealed a native-like structure for all analogs. Cytotoxicity and membrane binding assays showed that biological activity was maintained upon selenocysteine substitution. Overall, this study demonstrates the conservative nature of diselenide replacement while improving the folding of kalata B2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.